Abstract
The identification and validation of the targets of biologically active molecules is an important step in the field of chemical biology. While recent advances in proteomic and genomic technology have accelerated this identification process, the discovery of small molecule targets remains the most challenging step. A general method for the identification of these small molecule targets has not yet been established. To overcome the difficulty in target identification, new technology derived from the fields of genomics, proteomics, and bioinformatics has been developed. To date, pull-down methods using small molecules immobilized on a solid support followed by mass spectrometry have been the most successful approach. Here, we discuss current procedures for target identification. We also review the most recent target identification approaches and present several examples that illustrate advanced target identification technology.
Similar content being viewed by others
References
Austin CP, Brady LS, Insel TR, Collins FS (2004) NIH molecular libraries initiative. Science 306:1138–1139
Axelrod M, Ou Z, Brett LK, Zhang L, Lopez ER, Tamayo AT, Gordon V, Ford RJ, Williams ME, Pham LV, Weber MJ, Wang ML (2014) Combinatorial drug screening identifies synergistic co-targeting of Bruton’s tyrosine kinase and the proteasome in mantle cell lymphoma. Leukemia 28:407–410
Carson EE (2010) Natural products as chemical probes. ACS Chem Biol 5:639–653
Cha PH, Cho YH, Lee SK, Lee JH, Jeong WJ, Moon BS, Yun JH, Yang JS, Choi S, Yoon J, Kim HY, Kim MY, Kaduwal S, Lee W, Min DS, KimH Han G, Choi KY (2016) Small-molecule binding of the axin RGS domain promotes β-catenin and Ras degradation. Nat Chem Biol. doi:10.1038/nchembio.2103
Chernobrovkin A, Marin-Vicente C, Visa N, Zubarev RA (2015) Functional Identification of Target by Expression Proteomics (FITExP) reveals protein targets and highlights mechanisms of action of small molecule drugs. Sci Rep 5:1–9
Cho YS, Kwon HJ (2012) Identification and validation of bioactive molecule target through phenotypic screening. Bioorg Med Chem 20:1922–1928
Chou DHC, Vetere A, Choudhary A, Scully SS, Schenone M, Ting A, Gomez R, Burns SM, Lundh M, Vital T, Comer E, Faloon PW, Dancik V, Ciarlo C, Paulk J, Dai M, Reddy C, Sun H, Young M, Donato N, Jaffe J, Clemons PA, Palmer M, Carr SA, Svjreiber SL, Wagner BK (2015) kinase-independent small-molecule inhibition of JAK-STAT signaling. J Am Chem Soc 137:7929–7934
Crews CM, Splittgerber U (1999) Chemical genetics: exploring and controlling cellular processes with chemical probes. Trend in Biochem Sci 24:317–320
Dadvar P, Kovanich D, Folkers GE, Rumpel K, Raijmakers R, Heck AJ (2009) Phosphatidylethanolamine-binding proteins, including RKIP, exhibit affinity for phosphodiesterase-5 inhibitors. Chem Bio Chem 10:2654–2662
Dückert H, Pries V, Khedkar V, Menninger S, Bruss H, Bird AW, Maliga Z, Brockmeyer A, Janning P, Hyman A, Grimme S, Schürmann M, Preut H, Hübel K, Ziegler S, Kumar K, Waldmann H (2012) Natural product–inspired cascade synthesis yields modulators of centrosome integrity. Nat Chem Biol 8:179–184
Futamura Y, Muri M, Osada H (2013) Target identification of small molecules based on chemical biology approaches. Mol BioSyst 9:897–914
Galloway WRJD, Isidro-Llobet A, Spring DR (2010) Diversity-oriented synthesis as a tool for the discovery of novel biologically active small molecules. Nature Comm 1:80
Hall DA, Ptacek J, Snyder M (2007) Protein microarray technology. Mech Ageing Dev 128:161–167
Henzler-Wildman K, Kern D (2007) Dynamic personalities of proteins. Nature 450:964–972
Hirota T, Lee JW, St John PC, Sawa M, Iwaisako K, Noguchi T, Pongsawakul PY, Sonntag T, Welsh DK, Brenner DA, Doyle FJ, Schultz PG, Kay SA (2012) Identification of small molecule activators of cryptochrome. Science 337:1094–1097
Hoelder S, Clarke PA, Workman P (2012) Discovery of small molecule cancer drugs: successes, challenges and opportunities. Mol. Oncology 6:155–176
Hong JY (2011) Role of natural product diversity in chemical biology. Curr Opin Chem Biol 15:350–354
Huang J, Zhu H, Haggarty SJ, Spring DR, Hwang H, Jin F, Snyder M, Schreiber SL (2004) Finding new components of the target of rapamycin (TOR) signaling network through chemical genetics and proteome chips. Proc Nat Acad Sci USA 101:16594–16599
Inglese J, Johnson RL, Simeonov A, Menghang X, Zheng W, Austin CP, Auld DS (2007) High-throughput screening assays for the identification of chemical probes. Nature Chem Biol 3:466–479
Johnson K, Zhu S, Tremblay MS, Payette JN, Wang J, Bouchez LC, Meeusen S, Althage A, Cho CY, Wu X, Schultz PG (2012) A stem cell-based approach to cartilage repair. Science 336(6082):717–721
Jung HJ, Kwon HJ (2015) Target deconvolution of bioactive small molecules: the heart of chemical biology and drug discovery. Arch Pharmacal Res 38(9):1627–1641
Jung HJ, Shim JS, Lee J, Song YM, Park KC, Choi SH, Kim ND, Yoon JH, Mungai PT, Schumacker PT, Kwon HJ (2010) Terpestacin inhibits tumor angiogenesis by targeting UQCRB of mitochondrial complex III and suppressing hypoxia-induced reactive oxygen species production and cellular oxygen sensing. J Biol Chem 285:11584–11594
Kawatanin M, Osada H (2014) Affinity-based target identification for bioactive small molecules. Med Chem Comm 5:277–287
Khersonsky SM, Jung DW, Kang TW, Walsh DP, Moon HS, Jo H, Jacobson EM, Shetty V, Neubert TA, Chang YT (2003) Facilitated forward chemical genetics using a tagged triazine library. J Am Chem Soc 125(39):11804–11805
Kim YK, Lee JS, Bi X, Ha HH, Ng SH, Ahn YH, Lee JJ, Wagner BK, Clemons PA, Chang YT (2011) Binding of fluorophores to proteins depends on the cellular environment. Angew Chem Int Ed 50:2761–2763
Kitambi SS, Toledo EM, Usoskin D, Wee S, Harisankar A, Svensson R, Sigmundsson K, Kalderén C, Niklasson M, Kundu S, Aranda S, Westermark B, Uhrbom L, Andäng M, Damberg P, Nelander S, Arenas E, Artursson P, Walfridsson J, Forsberg Nilsson K, Hammarström LG, Ernfors P (2014) Vulnerability of glioblastoma cells to catastrophic vacuolization and death induced by a small molecule. Cells 157:313–328
Kumar NS, Young RN (2009) Design and synthesis of all-in-one 3-(1,1-difluoroprop-2-ynyl)-3H-diazirin-3-yl functional group for photo-affinity labeling. Bioorg Med Chem 17:5388–5395
Kwon HJ (2006) Discovery of new small molecules and targets towards angiogenesis via chemical genomics approach. Curr Drug Targets 7:397–405
Lee J, Bogyo M (2013) Target deconvolution techniques in modern phenotypic profiling. Curr Opin Chem Biol 17:118–126
Lee S, Nam Y, Koo JY, Lim D, Park J, Ock J, Kim J, Suk K, Park SB (2014) A small molecule binding HMGB1 and HMGB2 inhibits microglia-mediated neuroinflammation. Nature Chem Biol 10:1055–1060
Lehár J, Stockwell BR, Giaever G, Nislow G (2008) Combination chemical genetics. Nature Chem Biol 4:674–681
Lomenick B, Hao R, Jonai N, Chin RM, Aghajan M, Warburton S, Wang J, Wu RP, Gomez F, Loo JA, Wohlschlegel JA, Vondriska TM, Pelletier J, Herschman HR, Clardy J, Clarke CF, Huang J (2009) Target identification using drug affinity responsive target stability (DARTS). Proc Natl Acad Sci USA 106:21984–21989
Lomenick B, Olsen RW, Huang J (2011) Identification of direct protein targets of small molecules. ACS Chem Biol 6:34–46
McPherson M, Yang Y, Hammond PW, Kreider BL (2002) Drug receptor identification from multiple tissues using cellular-derived mRNA display libraries. Chem Biol 9:691–698
Mizuhara T, Oishi S, Ohno H, Shimura K, Matsuoka M, Fujii N (2013) Design and synthesis of biotin- or alkyne-conjugated photoaffinity probes for studying the target molecules of PD 404182. Bioorg Med Chem 21:2079–2087
Newman RH, Zhang J (2008) Small molecules and chemical tools at the interface. Nature Chem Biol 4:382–386
Okoye-Okafor UC, Bartholdy B, Cartier J, Gao EN, Pietrak B, Rendina AR, Rominger C, Quinn C, Smallwood A, Wiggall KJ, Reif AJ, Schmidt SJ, Qi H, Zhao H, Joberty G, Faelth-Savitski M, Bantscheff M, Drewes G, Duraiswami C, Brady P, Groy A, Narayanagari S-R, Antony-Debre I, Mitchell K, Wang HR, Kao Y-R, Christopeit M, Carvajal L, Barreyro L, Paietta E, Makishima H, Will B, Concha N, Adams ND, Schwartz B, McCabe MT, Maciejewski J, Verma A, Steidl U (2015) New IDH 1 mutant inhibitors for treatment of acute myeloid leukemia. Nat Chem Biol 11:878–886
Ong SE, Schenone M, Margolin AA, Li X, Do K, Doud MK, Mani DR, Kuai L, Wang X, Wood JL, Tolliday NJ, Koehler AN, Marcaurelle LA, Golub TR, Gould RJ, Schreiber SL, Carr SA (2009) Identifiying the proteins to which small-molecule probes and drugs bind in cells. Proc Nat Acad Sci 106:4617–4622
Pace CN, McGrath T (1980) Substrate stabilization of lysozyme to thermal and guanidine hydrochloride denaturation. J Biol Chem 255:3862–3865
Park J, Oh S, Park SB (2012) Discovery and target identification of an anti-proliferative agent in live cells using fluorescence difference in two-dimensional gel electrophoresis. Angew Chem Int Ed 22:5447–5451
Park H, Koo JY, Srikanth YVV, Oh S, Lee J, Park J, Park SB (2016) Nonspecific protein labeling of photoaffinity linker correlates with their molecular shapes in living cells. Chem Comm 52:5828–5831
Raj L, Ide T, Gurkar AU, Foley M, Schenone M, Li X, Tolliday NJ, Golub TR, Carr SA, Shamji AF, Stern AM, Mandinova A, Schreiber SL, Lee SW (2011) Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature 475:231–234
Roemer T, Davies J, Giaever G, Nislow C (2012) Bugs, drugs and chemical biology. Nature Chem Biol 8:46–56
Sadakane Y, Hatanaka Y (2006) Photochemical fishing approaches for identifying target proteins and elucidating the structure of a ligand-binding region using carbene-generated photoreactive probes. Anal Sci 22:209–218
Sato S, Murata A, Shirakawa T, Uesugi M (2010) Biochemical Target Isolation for Novices: affinity-Based Strategies. Chem Biol 17:616–623
Schenone M, Dančík V, Wagner VK, Clemons PA (2013) Target identification and mechanism of action in chemical biology and drug discovery. Nature Chem Biol 9:232–240
Schulz MM, Reisen F, Zgraggen S, Fischer S, Yuen D, Kang GJ, Chen L, Schneider G, Detmar M (2012) Phenotype-based high-content chemical library screening identifies statins as inhibitors of in vivo lymphangiogenesis. Proc Nat Acad Sci 109:E2665–E2674
Shiheido H, Terada F, Tabata N, Hayakawa N, Matsumura H, Takashima H, Ogawa Y, Du W, Yamada T, Shoji M, Sugai T, Doi N, Iijima S, Hattori Y, Yanagawa H (2012) A phthalimide derivative that inhibits centrosomal clustering is effective on multiple myeloma. PLoS One 7:e38878
Shim JS, Lee J, Park H-J, Park S-J, Kwon HJ (2004) A New Curcumin Derivative, HBC, Interferes with the Cell Cycle Progression of Colon Cancer Cells via Antagonization of the Ca2+/Calmodulin Function. Chem Biol 11:1455–1463
Sleno L, Emili A (2008) Proteomic methods for drug target discovery. Curr Opin Chem Biol 12:46–54
Smith E, Collins I (2015) Photoaffinity labeling in target- and binding-site identification. Future Med Chem 7:159–183
Stockwell B (2000) Chemical genetics: ligand-based discovery of gene function. Nature Rev Gene 1:116–125
Stockwell BR, Haggarty SJ, Schreiber SL (1999) High-throughput screening of small molecules in miniaturized mammalian cell-based assays involving post-translational modifications. Chem Biol 6:71–83
Su Y, Ge J, Zhu B, Yao S (2013) Target identification of biologically active small molecules via in situ methods. Curr Opin Chem Biol 17:768–775
Sumranjit J, Chung SJ (2013) Recent Advances in Target Characterization and Identification by Photoaffinity Probes. Molecules 18:10425–10451
Takakusagi Y, Takakusagi K, Sugawara F, Sakaguchi K (2010) Use of phage display technology for the determination of the targets phage display technology for the determination of the targets for small-molecule therapeutics. Exp Opin Drug Discovery 5:361–389
Terstappen GC, Schlüpen C, Raggiaschi R, Gaviraghi G (2007) Target deconvolution strategies in drug discovery. Nature Rev Drug Discovery 6:891–903
Theodoropoulos PC, Gonzales SS, Winterton SE, Rodriguez-Navas C, McKnight JS, Morlock LK, Hanson JM, Cross B, Owen AE, Duan Y, Moreno JR, Lemoff A, Mirzaei H, Posner BA, Williams NS, Ready JM, Nijhawan D (2016) Discovery of tumor-specific irreversible inhibitors of stearoyl CoA desaturase. Nat Chem Biol 12:218–225
Van Dorst B, Mehta J, Rouah-Martin E, De Coen W, Blust R, Robbens J (2011) The identification of cellular targets of 17beta estradiol using a lytic (T7) cDNA phage display approach. Toxicol In Vitro 25:388–393
Zhu S, Wurdak H, Wang J, Lyssiotis CA, Peters EC, Cho CY, Wu X, Schultz PG (2009) A small molecule primes embryonic stem cells for differentiation. Cell Stem Cell 4:416–426
Ziegler S, Pries V, Hedberg C, Waldmann H (2013) Target identification for small molecules: finding the needle in the haystack. Angew Chem Int Ed 52:2744–2792
Acknowledgments
This work was supported by research fund of Korea institute of Science and Technology (2Z04371).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lee, H., Lee, J.W. Target identification for biologically active small molecules using chemical biology approaches. Arch. Pharm. Res. 39, 1193–1201 (2016). https://doi.org/10.1007/s12272-016-0791-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-016-0791-z